Cargando…
Development of Phosphodiesterase–Protein-Kinase Complexes as Novel Targets for Discovery of Inhibitors with Enhanced Specificity
Phosphodiesterases (PDEs) hydrolyze cyclic nucleotides to modulate multiple signaling events in cells. PDEs are recognized to actively associate with cyclic nucleotide receptors (protein kinases, PKs) in larger macromolecular assemblies referred to as signalosomes. Complexation of PDEs with PKs gene...
Autores principales: | Tulsian, Nikhil K., Sin, Valerie Jia-En, Koh, Hwee-Ling, Anand, Ganesh S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156604/ https://www.ncbi.nlm.nih.gov/pubmed/34063491 http://dx.doi.org/10.3390/ijms22105242 |
Ejemplares similares
-
Impaired cAMP processivity by phosphodiesterase-protein kinase A complexes in acrodysostosis
por: Venkatakrishnan, Varun, et al.
Publicado: (2023) -
Discovery of a Phosphodiesterase
9A Inhibitor as a Potential Hypoglycemic Agent
por: Shao, Yong-xian, et al.
Publicado: (2014) -
Ligand-mediated changes in conformational dynamics of NpmA: implications for ribosomal interactions
por: Husain, Nilofer, et al.
Publicado: (2016) -
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
por: Reneerkens, Olga A. H., et al.
Publicado: (2008) -
Evaluation of Antidepressant and Anxiolytic Activity of Phosphodiesterase 3 Inhibitor - Cilostazol
por: Patel, Dipesh S., et al.
Publicado: (2012)